Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sialorrhea × Cyclophosphamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 63 Leukemia, Myeloid, Acute 62 Multiple Myeloma 61 Lymphoma, Large B-Cell, Diffuse 57 Lymphoma, Non-Hodgkin 53 Lymphoma 53 Leukemia, Lymphocytic, Chronic, B-Cell 51 Melanoma 50 Leukemia 50 Breast Neoplasms 45 Burkitt Lymphoma 42 Recurrence 39 Myelodysplastic Syndromes 39 Lymphoma, Follicular 38 Lymphoma, B-Cell 36 Lymphoma, Mantle-Cell 34 Ovarian Neoplasms 29 Neuroblastoma 29 Neoplasms 26 Lymphoma, B-Cell, Marginal Zone 25 Sarcoma 24 Carcinoma, Non-Small-Cell Lung 23 Hodgkin Disease 22 Neoplasm Metastasis 21 Triple Negative Breast Neoplasms 17 Hematologic Neoplasms 17 Neoplasms, Plasma Cell 15 Colorectal Neoplasms 15 Carcinoma, Renal Cell 15 Stomach Neoplasms 14

Interventions

Imiquimod 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡